Who Will Develop Pouchitis After Ileal Pouch–Anal Anastomosis?

Serum markers can be used to identify patients with ulcerative colitis most likely to have inflammatory complications after ileal pouch–anal anastomosis (IPAA), according to the May issue of Clinical Gastroenterology and Hepatology. More than 20% of individuals with ulcerative colitis eventually need surgery for this disease. Patients with fulminant or

Read more

Does Vitamin D Prevent Crohn’s Disease?

Women with higher intake of vitamin D are less likely to develop Crohn’s disease or ulcerative colitis, according to a study published in the March issue of Gastroenterology. Vitamin D deficiency has been described in patients with inflammatory bowel diseases (IBD), and administration of vitamin D to mice with colitis

Read more

Abdominal CT Radiation Risk

Patients with inflammatory bowel disease (IBD) and other gastrointestinal disorders can be exposed to high levels of radiation—mostly from abdominal computed tomography (CT) scans—reports the March issue of Clinical Gastroenterology and Hepatology. Access to high-quality facilities and technologic advances have increased the use of CT imaging of the GI tract.

Read more

What Does the Appendix Do, Anyway?

The appendix protects against recurrent infection by Clostridium difficile (C difficile) and possibly other pathogenic bacteria, according to a study published in the December issue of Clinical Gastroenterology and Hepatology. Although the human appendix is considered to be expendable, it contains gut-associated lymphoid tissue (GALT), which processes antigen and regulates

Read more

An Immune Culprit in IBD?

Patients with Crohn’s disease or ulcerative colitis have reduced levels of an important regulator of the immune response—the receptor for granulocyte-macrophage colony-stimulating factor (GM-CSF)—according to a study by Jonathan Goldstein et al. in the July issue of Gastroenterology. The inflammatory bowel diseases (IBD) ulcerative colitis and Crohn’s disease arise from

Read more

Tracking Crohn’s Therapy

Measuring blood levels of C-reactive protein (CRP), a marker of inflammation, is a good way to monitor recovery from Crohn’s disease (CD) in patients being treated with infliximab, according to Matthias Jürgens et al. in the May issue of Clinical Gastroenterology and Hepatology. CRP is a protein released into the blood

Read more

IBD Risk Beyond the Bowel

Venous thromboembolism (VTE) is a recurring problem for patients with inflammatory bowel disease (IBD), according to a clinical study by Gottfried Novacek et al. in this month’s issue of Gastroenterology. People with IBD have a high risk for developing blood clots, but it is not clear if they should receive

Read more

Curbing Crohn’s for the Long Term?

Most people with Crohn’s disease receive surgery, yet the disease comes back a short time later. A study in the July issue of Clinical Gastroenterology and Hepatology reports that giving patients low doses of infliximab immediately after surgery prevents disease recurrence over long time periods. Dario Sorrentino et al. began

Read more